Diabetes-induced renal vascular dysfunction is normalized by inhibition of epidermal growth factor receptor tyrosine...

Area of Science:

• Vascular Biology
• Endocrinology
• Pharmacology

Background:

• Diabetic complications often involve vascular dysfunction.
• The role of receptor tyrosine kinase (RTK) activation in diabetic renal artery dysfunction is unclear.
• Increased vasoconstrictor responses are observed in diabetic renal arteries.

Purpose of the Study:

• To investigate the role of tyrosine kinase (TK) activation in diabetic renal artery dysfunction.
• To determine if inhibiting TKs or epidermal growth factor receptor (EGFR) TK can modulate altered vasoreactivity in diabetic renal arteries.

Main Methods:

• Utilized streptozotocin-induced diabetes model in rats.
• Administered genistein (broad-spectrum TK inhibitor) and AG1478 (EGFR TK inhibitor) chronically.
• Assessed vasoreactivity of isolated renal artery ring segments to norepinephrine, endothelin-1, and angiotensin II.
• Analyzed protein levels of phosphorylated EGFR via Western blotting.

Main Results:

• Diabetic renal arteries exhibited significantly increased vasoconstrictor responses to agonists.
• Genistein and AG1478 treatments normalized these responses in diabetic animals without affecting blood glucose.
• Diadzein, an inactive genistein analogue, had no effect.
• Phosphorylated EGFR levels were elevated in diabetic renal arteries, and AG1478 treatment normalized EGFR levels.

Conclusions:

• Activation of TK pathways, specifically the EGFR TK signaling pathway, contributes to the development of diabetic vascular dysfunction in the renal artery.
• Targeting TKs may offer a therapeutic strategy for managing diabetic nephropathy-related vascular complications.